-
dedup_wf_001--a796cf47b544ac2b5dfb435d8b9f82c9
Study methodology. Table S2. Key inclusion and exclusion criteria. Table S3. Adjusted mean (95 % CI) FEV1 trough and peak responses compared to placebo after 4 weeks of... -
dedup_wf_001--4e2333716f09be81419eafbcd461c840
White blood cells (cells/μL) expressed as mean ± SD at the beginning (V1), after 2 weeks (V2) and after 6 weeks (V3) of intervention in all groups. Table S2 Lymphocyte subsets... -
The modulation of PCSK-9 and GAGs by 10-dehydrogingerdione and pentoxifylline...
: The hypolipidemic effect of 10-DHGD was previously reported owing to its anti-inflammatory and anti-oxidant properties. We further investigated the anti-inflammatory role of... -
Additional file 5: of Characterization and validation of potential therapeuti...
Table S2. Affinity of BK011 and Erbitux (Cetuximab) for EGFR. (DOCX 13Â kb) -
Additional file 1 of Assessment of developmental neurotoxicity induced by che...
Additional file 1: Table S1. Chemicals acting through similar MoA (alterations of BDNF levels): summary of their effects and mode of action (MoA) based on literature review,... -
Clinical assessment and patient-reported outcome measures in low-back pain – ...
Purpose: We aimed to map the physiotherapy practice in Sweden of clinical tests and patient-reported outcome measures in low-back pain (LBP), and to study advantages and... -
Additional file 1: Table S1. of Medical diagnosis as a linguistic game
RAEB part 1. Table S2. RAEB part 2. Table S3. RAEB part 3. Table S4. RAEB part 4. Note that the underscored pathophem (IPSS Score) is not yet included in the system. Table S5.... -
Additional file 1: of Treatment with insulin (analogues) and breast cancer ri...
ESM 1. Search strategy for each database, study selection and results. ESM 2. Characterization of cells lines. Additional materials and methods section. ESM 3. Method for... -
dedup_wf_001--d0830b4681e45b194d98dd865460d256
Delphi Study Survey of Clinicians who treat adults with ESRD: Second Survey. (DOCX 74Â kb) -
dedup_wf_001--37197f1963d995511680c2e5c54fd7d0
Table S1. and Table S2. Symptoms and signs used to define each non-diarrheal indications for antibiotics among children aged 2–59 months per Integrated Management for Childhood... -
Additional file 5: Table S4. of Epidemiology of taeniosis/cysticercosis in Eu...
Identified taeniosis cases in case reports in western Europe (1990–2015). Table S5. Aggregated taeniosis cases reported in authorities’ reports, epidemiological bulletins, and... -
Additional file 1: of Dosimetry methods and clinical applications in peptide ...
Table S1. Technical articles concerning dosimetry approaches. Table S2 Clinical studies using dosimetry in PRRT in NET. (DOCX 30Â kb) -
Additional file 1: Table S1. of Phase 1/2 study of pacritinib, a next generat...
Dose adjustment and toxicity management guidelines—non-hematologic toxicities. Table S2 Serious adverse events and deathsa occurring in phase 1 component of the study (n = 43).... -
Additional file 2: of Differential methylation as a diagnostic biomarker of r...
Table S1. MEDLINE via Ovid search terms adapted for use in other databases. Table S2. Quality appraisal and data extraction template form for case-control studies. Table S3.... -
A phase separation in a protonated layered nickel titanate to form Ni-doped a...
We report a simple methodology for the preparation of an efficient visible-light responsive TiO2 photocatalyst through acid treatment of a lepidocrocite-type layered nickel... -
dedup_wf_001--3f673ae19b780377fbe4d79839ece93c
Table S1. List of 17 chronic conditions categories and corresponding International Classification of Disease, 9th and 10th Revisions (ICD-9/ICD-10). This table includes all... -
MOESM2 of Scientific validation of the antimicrobial and antiproliferative po...
Additional file 2. In vitro cytotoxicity study using RD, L20B and Hep2 cell lines by MTT assay-culture medium, stock cultures, test dilutions and determination of cytotoxicity... -
MOESM5 of Peripheral neuropathy in metachromatic leukodystrophy: current stat...
Additional file 5: A more detailed description of literature cases treated with immunomodulatory drugs. -
dedup_wf_001--936070a3f52b841fc5f05db4c777b057
Additional file 3: Table S3. Cox multivariate analysis for the risk of major amputation after exclusion of patients with CKD defined by eGFR -
dedup_wf_001--f7295cfb50f67064f85ed17fe9b11b7f
Table S1. Final concentrations of antibiotics in drug susceptibility test. Table S3. Drug susceptibility of recombinant M. smegmatis transformed with Rv0071 or Rv0074. Table S4....
